Simultaneous splenectomy improving the outcomes of patients with hepatocellular carcinoma, cirrhosis and portal hypertension treated with hepatectomy

Simultaneous splenectomy improving the outcomes of patients with hepatocellular carcinoma, cirrhosis and portal hypertension treated with hepatectomy

Abstract Aims Patients with cirrhosis and clinically significant portal hypertension (CSPH) usually have concomitant secondary hypersplenism, and splenectomy (Spx) is an option for treating these patients in the Asia‐Pacific region. CSPH is the most important risk factor for postoperative liver dysf...

Full description

Bibliographic Details
Main Authors: Fuchen Liu, Xinggang Guo, Wenli Zhang, Minghao Zou, Jian Huang, Wei Dong, Jinmin Zhang, Xiuli Zhu, Zeya Pan, Wan Yee Lau, Weiping Zhou, Hui Liu
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Portal Hypertension & Cirrhosis
Subjects:
clinically significant portal hypertension
HCC
hepatectomy
posthepatectomy liver dysfunction
Splenectomy
Online Access:https://doi.org/10.1002/poh2.29

Internet

https://doi.org/10.1002/poh2.29

Similar Items